Martin Murphy and Chris Hollowood provide an overview of Syncona's strategy, as it scales for growth to deliver impact for patients and strong returns for shareholders.
All data presented as of 30 September 2022.
- About us
- Our people
- Portfolio
- Sustainability
- News and insights
- Investors
- Contact
